THTX Theratechnologies, Inc. Total Asset Value of Company
Theratechnologies Inc. (THTX) focuses on developing oncology and immunology treatments for the global market, mitigating risks through a broad development pipeline. The stock's price history confirms this trajectory, with total assets amounting to 60.74. Physicians value Theratechnologies Inc. (THTX) for its therapies targeting rare metabolic disorders and HIV. The technological foundation relies on packaging automation and the implementation of digital logistics control.
Analytical breakdowns and data insights for company Theratechnologies Inc (THTX)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Theratechnologies Inc.|THTX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Theratechnologies, Inc|THTX - Company Aggregate Debts|Debts to Book Capitalization Theratechnologies, Inc|THTX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Theratechnologies|Interim Coverage Ratio theratech.com
- net income and valuation multiples indicators:
Fundamental valuation:Theratechnologies Inc.
Total assets represent the aggregate value of the company's resources, calculated inversely via return on assets (ROA). For Theratechnologies Inc. (THTX), this metric reflects the capitalization of capacities for peptide drug production and the development of therapies for endocrine disorders. By analyzing fluctuations in total assets, an investor can identify the impact of credit conditions on the pace of business expansion. A local decline in this metric amid margin compression signals risks regarding the efficiency of asset management.
Key competitors
Total Business Assets ARGX|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|SVRA: Cumulative Company Assets|Rigel Corp - Aggregate Business Assets|ANAB: Company Total Assets|astriatx.com - Aggregate Asset Value|ENGN (enGene) - Company Total Assets|Company Assets RAPT Therapeutics Inc. RAPT|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Aggregate Asset Value|Company Total Assets KYTX (Kyverna Therapeutics)|Company Total Assets tizianalifesciences.com TLSA|CABA: Cumulative Company Assets|Ventyx Biosciences Inc. - Aggregate Business Assets|AVTX: Company Total Assets|Company Assets Eledon Pharmaceuticals, Inc (ELDN)|AGEN (Agenus) - Company Total Assets|Cumulative Company Assets climbbio.com (CLYM)|Company Total Assets ZURA|ATYR (aTyr Pharma Inc) - Aggregate Asset Value|Aggregate Company Assets Adagene Inc. ADAG|IMA: Total Business Assets|STTK - Aggregate Company Assets|Company Assets Equillium, Inc.|connectbiopharm.com (CNTB) - Aggregate Company Assets|IMUX (Immunic) - Aggregate Company Assets|Aggregate Company Assets Atara Biotherapeutics, Inc.|Company Assets InflaRx GmbH IFRX|Company Total Assets XFOR|adicetbio.com (ACET) - Company Balance Sheet Assets|Company Total Assets CELU (Celularity)|Company Total Asset Base INmune Bio Inc (INMB)|Barinthus Bio - Company Total Assets|Company Assets Kezar Life Sciences Inc|SAB Biotherapeutics (SABS) - Aggregate Company Assets|AKTX - Company Total Asset Base|Cumulative Company Assets ENLV|QTTB: Aggregate Asset Value|Company Total Assets GOVX|Company Total Asset Base Edesa Biotech Corp|Aggregate Company Assets iBio, Inc. IBIO|CARM: Total Business Assets|XTL Biopharmaceuticals Ltd. - Company Total Assets|Bolt Biotherapeutics (BOLT) - Cumulative Company Assets|HCWB (hcwbiologics.com) - Cumulative Company Assets|APVO - Company Total Asset Base|Cumulative Company Assets AIM|ADTX (Aditxt Corp) - Aggregate Business Assets|Company Total Assets GRI|XRTX (XORTX Therapeutics Inc) - Aggregate Asset Value|ReShape Lifesciences - Cumulative Company Assets|Aggregate Business Assets REVB (Revelation Biosciences Corp)|INDP: Cumulative Company Assets|SCNI (scinai.com) - Total Business Assets|calcimedica.com (CALI) - Aggregate Company Assets|Total Asset Value of Company AFMD (Affimed N.V.)|ALLK (Allakos Inc) - Company Total Assets|HOOK: Aggregate Asset Value|Company Total Assets IGMS|Company Total Assets iteostherapeutics.com (ITOS)|Aggregate Company Assets Ocean Biomedical OCEA|Aggregate Asset Value TCBP|THRD - Aggregate Company Assets